USAC USA Compression Partners, LP Insider Trading

Porter Christopher W sold 40,000 shares of USAC at $26.64 on 2026-02-20, reducing holdings to 108,001 shares.

Porter Christopher W sold 40,000 shares (40.0K shares) of USA Compression Partners, LP (USAC) at $26.64, representing a -27.0% reduction from his pre-transaction holdings of 148,001 shares. The transaction value was $1,065,600.00 ($1.1M). The stock has appreciated 13.2% over the prior 90 days and currently trades at $26.77, marginally above the transaction price. With USAC valued at a P/E of 32.25 and showing 5.0% annual revenue growth against $250.3M quarterly revenue and $34.5M quarterly net income, this represents a material stake reduction by an insider during a period of recent price strength.

Director Whitehurst buys 10,000 USAC shares at $26.75; holdings rise 42.3% to 33.6K; prior 5 buys at this ticker all well-timed at 90-day mark

Whitehurst purchased 10,000 shares at $26.75, increasing his USAC position by 42.3% to 33.6K shares, demonstrating a material accumulation within a concentrated timeframe. His prior 5 trades at this ticker (all executed 2025-05-08) each generated positive 90-day returns ranging from 1.0% to 1.6%, establishing a pattern of well-timed buys where the stock subsequently appreciated. The current 30-day price move of +7.7% is already consistent with the early-stage behavior seen after his May purchases, which averaged +10.4% in their first 30 days. At a P/E of 32.41 against a 5.0% annual revenue growth rate and current market cap of $3.9B, the company's valuation has room for interpretation, but the insider's repeated accumulation at this ticker—particularly after all five prior buys proved profitable at the 90-day horizon—warrants investor attention to the reasons driving sustained conviction in the position.

Director Whitehurst Bradford D. purchased 10,000 shares at blended $23.50 for $234,982.44 on 2025-05-08.

Whitehurst Bradford D., a director of USA Compression Partners, LP, executed 5 separate purchases totaling 10,000 shares for $234,982.44, increasing his holdings by 73.4% to 23.6K shares. The transaction occurred at a blended average price of $23.50, only $0.05 below current market price of $23.55, and represents a material addition to his stake in the company. His prior buy at this ticker on 2024-05-10 resulted in a 90-day return of -9.9%, indicating a pattern of poorly-timed entries at USAC; his cross-ticker track record shows an 80% win rate on buys with a +3.2% 90-day average, but this cross-ticker strength has not translated to USAC-specific outcomes. The company trades at a P/E of 28.72 with recent quarterly revenue of $245.2M, net income of $20.5M, and annual revenue growth of +12.3%, while the stock remains -19.5% from its 52-week high of $29.24.

EIG Veteran Equity Aggregator sold 2,776,383 shares of USAC at $23.00 (50.2% of holdings) for $63.9M on 2024-06-14.

EIG Veteran Equity Aggregator executed a substantial reduction in its USAC position, selling 2,776,383 shares (50.2% of pre-transaction holdings) at $23.00, reducing its stake from 5,530,698 shares to 2,754,315 shares. This high-volume transaction occurred as the stock trades at $24.12 currently, -14.6% from its 52-week high of $28.24, and follows a 90-day decline of -14.4%. The insider's cross-ticker track record shows a 90d well-timed rate of 9.09% across 20 prior sells, but at USAC specifically, 0 of 0 measurable 90-day outcomes on prior sells were well-timed; the most recent USAC sale on 2024-05-17 showed -3.1% at the 30-day mark. The company's fundamentals remain steady with revenue growth of +20.1% year-over-year and net income of $23,573,000.00 on quarterly revenue of $229,276,000.00, though the elevated P/E of 34.96 reflects market expectations. This magnitude of reduction in holdings by a major shareholder, combined with the mixed track record at this ticker and recent price weakness, warrants investor scrutiny of whether the insider's assessment of valuation has shifted.